Using machine learning to understand non-cancer deaths in cancer patients
Screening and confirmatory machine learning for explainable modeling of non-cancer deaths in cancer patients
['FUNDING_R37'] · RUTGERS BIOMEDICAL AND HEALTH SCIENCES · NIH-11061641
This study is looking at how we can use technology to better understand and predict why some cancer patients, especially those with disabilities, may face higher risks of dying from causes other than cancer, so we can improve their care and help them live longer, healthier lives.
Quick facts
| Phase | ['FUNDING_R37'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | RUTGERS BIOMEDICAL AND HEALTH SCIENCES (nih funded) |
| Locations | 1 site (Newark, UNITED STATES) |
| Trial ID | NIH-11061641 on ClinicalTrials.gov |
What this research studies
This research investigates how machine learning (ML) can be utilized to better understand and predict non-cancer deaths among cancer patients, particularly those with disabilities. The study aims to improve the performance of ML models to address health disparities faced by these patients. By analyzing real-world datasets, the research will explore how the experiences of cancer patients with disabilities differ from those without, focusing on specific cancer types such as breast, cervical, and colorectal cancers. The goal is to enhance survival rates and provide more tailored healthcare solutions for this vulnerable population.
Who could benefit from this research
Good fit: Ideal candidates for this research include cancer patients, particularly those with disabilities, who are diagnosed with breast, cervical, or colorectal cancers.
Not a fit: Patients without cancer or those who do not have disabilities may not receive direct benefits from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved survival rates and healthcare strategies for cancer patients with disabilities.
How similar studies have performed: While the use of machine learning in healthcare is growing, this specific approach focusing on non-cancer deaths in cancer patients with disabilities is relatively novel and has not been extensively tested.
Where this research is happening
Newark, UNITED STATES
- RUTGERS BIOMEDICAL AND HEALTH SCIENCES — Newark, UNITED STATES (ACTIVE)
Researchers
- Principal investigator: ZHANG, LANJING — RUTGERS BIOMEDICAL AND HEALTH SCIENCES
- Study coordinator: ZHANG, LANJING
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Conditions: Breast Cancer Patient, Cancer Patient, Cancers, Cervical Cancer, Cervix Cancer